E-Learning

(Bloomberg) -- A double-digit selloff in UnitedHealth Group Inc. is dragging down the blue-chip Dow Jones Industrial Average, pushing it toward a day of historical underperformance.Most Read from BloombergTrump Signs Executive Orders on Federal Purchasing, Office SpaceDOGE Places Entire Staff of Federal Homelessness Agency on LeaveHow Did This Suburb Figure Out Mass Transit?Why the Best Bike Lanes Always Get BlamedNashville’s $3 Billion Transit Plan Brings a Call for Zoning ReformThe Dow Jones I

New U.S. Bank CEO Gunjan Kedia outlined a focused strategy of urgency, expense discipline, and organic growth to regain investor confidence amid turbulent economic headwinds.

Microsoft, PayPal downgraded: Wall Street's top analyst calls

(Bloomberg) -- US financial assets are at risk of “mirroring dynamics of the UK and emerging markets” as the Trump administration embraces protectionism, says Pacific Investment Management Co.Most Read from BloombergTrump Signs Executive Orders on Federal Purchasing, Office SpaceDOGE Places Entire Staff of Federal Homelessness Agency on LeaveHow Did This Suburb Figure Out Mass Transit?Why the Best Bike Lanes Always Get BlamedNashville’s $3 Billion Transit Plan Brings a Call for Zoning Reform“Rap

Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside risk because they lack the scale and staying power of their larger competitors.

Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings, partly because their firms often seek other business from the same companies they cover.

While the S&P 500 includes industry leaders, not every stock in the index is a winner. Some companies are past their prime, weighed down by poor execution, weak financials, or structural headwinds.

The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.

Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly optimistic forecasts.

Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptical because analysts face institutional pressures that can sometimes lead to overly optimistic forecasts.